Image

Global Depression Screening Market – Industry Trends and Forecast to 2030

Healthcare

Image

Global Depression Screening Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Aug 2023
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Depression Screening Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 10,624.91 USD Million
Diagram Market Size (Forecast Year) USD 15,829.87 USD Million
Diagram CAGR %

Major Markets Players

  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Global Depression Screening Market, By Disease Type (Anxiety, Depression, Mood Disorders, Bipolar Disorders, Eating Disorders, Psychotic Disorders, Others), Diagnosis (Psychological Test, Depression Screening Tests, Lab Tests, Others), Treatment (Medication, Deep Brain Stimulation, Brain-Stimulation Treatments,) End User (Hospitals and Clinics, Academic Institutes, Medical Research Centers, Others) - Industry Trends and Forecast to 2030.

Depression Screening Market

Depression Screening Market Analysis and Size

Depression screening, also known as the depression test, is largely used to find out if the patient is clinically depressed. It is a type of a common illness, but depression varies from regular feelings of sadness and can also affect the thinking process and behavior of a person.

The increasing prevalence of mental disorders across the globe is among the significant factors fueling the growth and demand for the global depression screening market. In addition, the easy availability of advanced diagnostic and treatment methods and the rising number of patients who have mental illness and related disorders are also contributing to the growth in the global market over the forecast period of 2023 to 2030 Also, the rapidly increasing funds in research activities and rapidly changing healthcare sector are also lifting the growth of the market. Furthermore, the increasing per capita disposable income is also one of the significant factors flourishing the growth of the global depression screening market. The rising number of patients who have mental illness and related disorders will also make sure high industry growth over the forecast period.

Data Bridge Market Research analyses that the global depression screening market was valued at USD 10,624.91 million in 2022 and is further estimated to reach USD 15,829.87 million by 2030, and is expected to grow at a CAGR of 5.11% during the forecast period of 2023 to 2030. The Data Bridge Market Research team curated market report includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Depression Screening Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Year

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million

Segments Covered

By Disease Type (Anxiety, Depression, Mood Disorders, Bipolar Disorders, Eating Disorders, Psychotic Disorders, Others), Diagnosis (Psychological Test, Depression Screening Tests, Lab Tests, Others), Treatment (Medication, Deep Brain Stimulation, Brain-Stimulation Treatments,) End User (Hospitals and Clinics, Academic Institutes, Medical Research Centres, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Johnson & Johnson Services Inc. (U.S.), AstraZeneca (U.K.), Bristol-Myers Squibb Company (U.S.), Lilly (U.S.) , F. Hoffmann-La Roche Ltd., (Switzerland), Novartis AG (Switzerland), Otsuka Holdings Co.,Ltd. (Japan), Pfizer Inc.(U.S.), GSK plc (U.K.), Janssen Global Services LLC, (Belgium), Meiji Holdings Co., Ltd (Japan), Ltd., Abbott (U.S.), Jazz Pharmaceuticals Inc. (Ireland), AbbVie Inc. (U.S.), 3M (U.S.), Acadia Pharmaceuticals Inc.(U.S.), Medtronic (Ireland), Bausch Health Companies Inc.(Canada), and Merck KGaA (Germany) among other

Market Opportunities

  • The rapid rise in the digital health technologies for mental health and caregivers as well as the increasing focus areas in the care continuum are prevention and recovery are offering significant growth opportunities for the market in the forecast period
  • Collaboration between screening tool providers, health organizations, and mental health professionals can lead to the development of comprehensive depression screening programs. Partnerships that combine technology, research and mental health expertise can create integrated solutions that meet the needs of people seeking depression treatment
  • Rising focus on early intervention and prevention strategies in mental health. Screening for depression can play a vital role in identifying individuals at risk for depression in the early stages of the disease. This provides an opportunity to implement targeted interventions and preventive measures

Market Definition

The market includes both traditional screening methods, such as questionnaires and interviews, and technologically advanced solutions, such as digital platforms, mobile applications, and wearable device that enable convenient remote screening. It includes various screening tools, techniques, and services to identify and assess symptoms of depression so that health professionals can make an accurate diagnosis and develop an appropriate treatment plan increase. The global depression screening market serves individuals seeking mental health assessment, healthcare providers, mental health organizations, and other stakeholders involved in the diagnosis and management of depression. It plays a crucial role in early identification, intervention, and prevention of depression, aiming to improve mental health outcomes and enhance overall well-being.

Global Depression Screening Market Dynamics

Drivers

  • Increasing Prevalence of Depression

The rising prevalence of depression across the globe is the primary driver for the growth of the global depression screening market. Stress, lifestyle changes, and social pressure have contributed to the increased prevalence of depression, creating a need for effective screening methods, which is expected to drive market growth.

  • Rising Awareness and Mental Health Advocacy

Awareness of mental health issues, including depression, is growing around the world. An increasing number of organizations, government initiatives, and celebrity advocacy have reduced the stigma associated with mental health and encouraged more people to seek testing and treatment options, which is expected to drive the market growth

  • Technological Advancements in Screening Tools

The growing advancement in technology has led to the development of innovative screening tools and solutions for depression. Digital platforms, mobile apps, and mobile devices equipped with depression screening features have made it easier and easier to assess people's mental health status, which has fuelled market growth.

Opportunities

  • Growing Adoption of Telehealth and Remote Screening

The increasing adoption of telehealth services provides an opportunity for remote depression screening. Virtual consultations and digital screening tools enable individuals to access screening services from the comfort of their homes, eliminating geographical barriers and improving access to mental health care.

  • Increasing Technological Advancements
  • Continued integrating artificial intelligence technologies, such as machine learning algorithms, into depression screening tools offers opportunities for more accurate and efficient assessments. Exam platforms powered by AI can analyze large data sets, identify patterns and deliver personalized exam results, improving the overall exam process, which helps to create an opportunity for the market growth.

Restraint

  • Limited Awareness and Stigma in Certain Regions

Although mental health awareness is growing worldwide, there are still areas where awareness and stigma around mental health issues, such as depression, are still limited. A lack of awareness may hinder the adoption of depression control services in these regions, thereby hindering market growth.

Challenges

  • Lack of Quality Assurance and Standardization

Ensuring the quality and standardization of depression screening tools and methods across regions and health facilities can be challenging. To maintain the reliability of depression screening programs, it is important to develop uniform screening guidelines and protocols and establish criteria for accuracy and reliability.

This global depression screening market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global depression screening market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In April 2021, the company received breakthrough device designation from the FDA for its digital diagnostic and therapeutic platform for autism spectrum disorder (ASD) and comorbid behavioral health conditions like depression.
  • In September 2020, Pear Therapeutics received FDA clearance for its digital therapeutic called reSET-O. This prescription digital therapeutic is designed to treat opioid use disorder with a co-occurring moderate-to-severe depressive disorder.

Global Depression Screening Market Scope

The global depression screening market is segmented into five notable segments based on disease type, diagnosis, treatment, and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Disease Type

  • Anxiety
  • Mood disorders
  • Depression
  • Bipolar disorders
  • Psychotic disorders
  • Eating disorders
  • Others

Diagnosis

  • Psychological test
  • Lab tests
  • Depression screening tests
  • Others

Treatment

  • Medication
  • Brain-stimulation treatments
  • Deep brain stimulation

End User

  • Hospitals and clinics
  • Medical research centers
  • Academic institutes
  • Others

Global Depression Screening Market Regional Analysis/Insights

The global depression screening market is analyzed, and market size insights and trends are provided based on disease type, diagnosis, treatment, and end user.

The countries covered in this market report are the U.S., Canada, and Mexico in North America, Germany, France, the U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to dominate the global depression screening market due to the increasing research in depression screening and development.

The U.S. is expected to dominate the North America region due to the rise in healthcare expenditure and the high prevalence of dental diseases seen in the country. Germany is expected to dominate Europe due to the increasing technology and reliability of healthcare services, which also deliver infotainment services. The demand in this region is projected to be driven by a rise in dental diseases with the growing integration of healthcare data with portable devices. China is expected to dominate the Asia-Pacific region due to exponential awareness of cancer diagnostics and consultancy services in the country.

The country section of the report also provides individual market-impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as downstream and upstream value chain analysis, technical trends, Porter's five forces analysis, and case studies are some pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges due to large or scarce competition from local and domestic brands and the impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global depression screening market also provides you with a detailed market analysis for every country’s growth in healthcare expenditure for capital equipment, installed base of different kind of products for global depression screening market, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and their impact on the market. The data is available for the historic period 2015-2020.

Competitive Landscape and Global Depression Screening Market Share Analysis

The global depression screening market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.

Some of the major players operating in the global depression screening market are:

  • Johnson & Johnson Services Inc. (U.S.)
  • AstraZeneca (U.K.)
  • Bristol-Myers Squibb Company (U.S.)
  • Lilly (U.S.)
  • F. Hoffmann-La Roche Ltd., (Switzerland)
  • Novartis AG (Switzerland)
  • Otsuka Holdings Co., Ltd. (Japan)
  • Pfizer Inc. (U.S.)
  • GSK plc (U.K.)
  • Janssen Global Services LLC, (Belgium)
  • Meiji Holdings Co., Ltd (Japan)
  • Abbott (U.S.)
  • Jazz Pharmaceuticals Inc. (Ireland)
  • AbbVie Inc. (U.S.)
  • 3M (U.S.)
  • Acadia Pharmaceuticals Inc. (U.S.)
  • Medtronic (Ireland)
  • Bausch Health Companies Inc. (Canada)
  • Merck KGaA (Germany)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The Depression Screening Market will be worth USD 15,829.87 million by 2030.
The Depression Screening Market Growth Rate is 5.11% during the forecast period
The Increasing Prevalence of Depression, Rising Awareness and Mental Health Advocacy and Technological Advancements in Screening Tools are the Growth drivers of the Depression Screening Market.
The disease type, diagnosis, treatment, and end user are the factors on which the Depression Screening Market research is based.
The company received breakthrough device designation from the FDA for its digital diagnostic and therapeutic platform for autism spectrum disorder (ASD) and comorbid behavioral health conditions like depression and Pear Therapeutics received FDA clearance for its digital therapeutic called reSET-O. This prescription digital therapeutic is designed to treat opioid use disorder with a co-occurring moderate-to-severe depressive disorder are the latest developments in the Depression Screening Market.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials